Continuous-infusion Ifosfamide and Doxorubicin Combination as Second-Line Chemotherapy for Recurrent or Refractory Osteosarcoma Patients in China: a Retrospective Study
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.